![](/img/cover-not-exists.png)
Combination of the dual PIM/PI3-kinase inhibitor IBL-202 and venetoclax is effective in diffuse large B-cell lymphoma
Gifford, Grace, Stevenson, William, Best, GilesJournal:
Leukemia & Lymphoma
DOI:
10.1080/10428194.2020.1795156
Date:
July, 2020
File:
PDF, 1.74 MB
2020